J
Jiri Jarkovsky
Researcher at Masaryk University
Publications - 203
Citations - 3822
Jiri Jarkovsky is an academic researcher from Masaryk University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 29, co-authored 168 publications receiving 2669 citations. Previous affiliations of Jiri Jarkovsky include Slovak Academy of Sciences.
Papers
More filters
Journal ArticleDOI
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Pavel Osmancik,Dalibor Herman,Petr Neuzil,Pavel Hala,Milos Taborsky,Petr Kala,Martin Poloczek,Josef Stasek,Ludek Haman,Marian Branny,Jan Chovančík,Pavel Červinka,Jiri Holy,Tomas Kovarnik,David Zemánek,Stepan Havranek,Vlastimil Vančura,Jan Opatrny,Petr Peichl,Petr Tousek,Veronika Lekesova,Jiri Jarkovsky,Martina Novackova,Klára Benešová,Petr Widimsky,Vivek Y. Reddy,Prague Trial Investigators +26 more
TL;DR: Among patients at high risk for stroke and increased risk of bleeding, LAAC was noninferior to DOAC in preventing major AF-related cardiovascular, neurological, and bleeding events.
Journal ArticleDOI
Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study.
Zuzana Motovska,Ota Hlinomaz,Roman Miklík,Milan Hromádka,Ivo Varvarovsky,Jaroslav Dušek,Jiri Knot,Jiri Jarkovsky,Petr Kala,Richard Rokyta,František Toušek,Petra Kramarikova,Bohumil Majtan,Stanislav Šimek,Marian Branny,Jan Mrózek,Pavel Červinka,Jiri Ostransky,Petr Widimsky +18 more
TL;DR: No randomized head-to-head comparison of the efficacy and safety of ticagrelor and prasugrel has been published in the 7 years since the higher efficacy of these newer P2Y12 inhibitors w...
Journal ArticleDOI
Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial.
Jan Bělohlávek,J. Šmalcová,D. Rob,O. Franěk,Ondrej Smid,Milana Pokorna,Jan Horák,Vratislav Mrazek,Tomas Kovarnik,David Zemánek,Ales Kral,Stepan Havranek,P Kaválková,Lucie Kompelentova,Helena Tomková,Alan Mejstrik,Jaroslav Valasek,David Peran,Jaroslav Pekara,Jan Rulisek,Martin Balik,Michal Huptych,Jiri Jarkovsky,Jan Malik,Anna Valerianova,Frantisek Mlejnsky,Petr Kolouch,Petra Havránková,D. Romportl,Arnošt Komárek,Aleš Linhart +30 more
TL;DR: Among patients with refractory out-of-hospital cardiac arrest, the bundle of early intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and invasive assessment and treatment did not significantly improve survival with neurologically favorable outcome at 180 days compared with standard resuscitation.
Journal ArticleDOI
Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry
Jindrich Spinar,Jiri Parenica,Jiri Vitovec,Petr Widimsky,Aleš Linhart,Marián Fedorco,Filip Málek,Cestmir Cihalik,Lenka Špinarová,Roman Miklík,Marian Felsoci,Miroslav Bambuch,Ladislav Dušek,Jiri Jarkovsky +13 more
TL;DR: Invasive ventilation and age over 70 years were the most important predictive factors for mortality in both genders with or without cardiogenic shock, and low systolic blood pressure, low cholesterol level, hyponatremia, hyperkalemia, the use of inotropic agents and norepinephrine were predictive parameters for in-hospital mortality in patients without carduogenic shock.
Journal ArticleDOI
1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor
Zuzana Motovska,Ota Hlinomaz,Petr Kala,Milan Hromádka,Jiri Knot,Ivo Varvarovsky,Jaroslav Dušek,Jiri Jarkovsky,Roman Miklík,Richard Rokyta,František Toušek,Petra Kramarikova,Michal Svoboda,Bohumil Majtan,Stanislav Šimek,Marian Branny,Jan Mrózek,Pavel Červinka,Jiri Ostransky,Petr Widimsky +19 more
TL;DR: Prasugrel and ticagrelor are similarly effective during the first year after MI and patients who were economically motivated to switch to clopidogrel had a lower risk of major cardiovascular events; however, they also had lower ischemic risk.